Immunostaining of p53 protein in ovarian carcinoma: correlation with histopathological data and clinical outcome
- 1 August 1996
- journal article
- Published by Springer Nature in Zeitschrift für Krebsforschung und Klinische Onkologie
- Vol. 122 (8), 489-494
- https://doi.org/10.1007/bf01187161
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Tumor suppressor genesCurrent Opinion in Genetics & Development, 1994
- Clinical Implications of the p53 Tumor-Suppressor GeneNew England Journal of Medicine, 1993
- Detection of p53 Gene Mutations in Human Ovarian and Endometrial Cancers by Polymerase Chain Reaction‐Single Strand Conformation Polymorphism AnalysisJapanese Journal of Cancer Research, 1992
- High Incidence of p53 Gene Mutation in Human Ovarian Cancer and Its Association with Nuclear Accumulation of p53 Protein and Tumor DNA AneuploidyJapanese Journal of Cancer Research, 1992
- Wild-type p53 mediates positive regulation of gene expression through a specific DNA sequence element.Genes & Development, 1992
- p53 Mutations in Human CancersScience, 1991
- The p53 tumour suppressor geneNature, 1991
- Correlation of metabolic stability and altered quaternary structure of oncoprotein p53 with cell transformationExperimental Cell Research, 1991
- Different Tumor-Derived p53 Mutants Exhibit Distinct Biological ActivitiesScience, 1990
- Mutations in the p53 gene occur in diverse human tumour typesNature, 1989